If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


 
Deep Track Biotechnology Master Fund, Ltd.
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Director
Date:09/19/2025
 
Deep Track Special Opportunities Fund, LP
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner of the Investment Manager
Date:09/19/2025
 
Deep Track Capital, LP
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner
Date:09/19/2025
 
David Kroin
 
Signature:/s/ David Kroin
Name/Title:David Kroin
Date:09/19/2025